Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study | Zendy

JeanYves Reginster | Zendy; Ego Seeman | Zendy; M.C. de Vernejoul | Zendy; S. Adámi | Zendy; Juliet Compston | Zendy; C. Phenekos | Zendy; J.-P. Devogelaer | Zendy; Díaz Curiel M | Zendy; A. Sawicki | Zendy; Stefan Goemaere | Zendy; O. H. Sørensen | Zendy; Dieter Felsenberg | Zendy; Pierre J. Meunier | Zendy

Open Access

Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study

Author(s) -

JeanYves Reginster,

Ego Seeman,

M.C. de Vernejoul,

S. Adámi,

Juliet Compston,

C. Phenekos,

J.-P. Devogelaer,

Díaz Curiel M,

A. Sawicki,

Stefan Goemaere,

O. H. Sørensen,

Dieter Felsenberg,

Pierre J. Meunier

Publication year - 2005

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2004-1774

Subject(s) - strontium ranelate , osteoporosis , medicine , postmenopausal osteoporosis , peripheral , bone mineral

Strontium ranelate, a new oral drug shown to reduce vertebral fracture risk in postmenopausal women with osteoporosis, was studied in the Treatment of Peripheral Osteoporosis (TROPOS) study to assess its efficacy and safety in preventing nonvertebral fractures also.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research